Tags

Type your tag names separated by a space and hit enter

Vaccine hesitancy among communities in ten countries in Asia, Africa, and South America during the COVID-19 pandemic.
Pathog Glob Health. 2022 06; 116(4):236-243.PG

Abstract

Vaccine hesitancy is considered one of the greatest threats to the ongoing coronavirus disease 2019 (COVID-19) vaccination programs. Lack of trust in vaccine benefits, along with concerns about side effects of the newly developed COVID-19 vaccine, might significantly contribute to COVID-19 vaccine hesitancy. The objective of this study was to determine the level of vaccine hesitancy among communities in particular their belief in vaccination benefits and perceived risks of new vaccines. An online cross-sectional study was conducted in 10 countries in Asia, Africa, and South America from February to May 2021. Seven items from the WHO SAGE Vaccine Hesitancy Scale were used to measure a construct of belief in vaccination benefit, and one item measured perceived riskiness of new vaccines. A logistic regression was used to determine which sociodemographic factors were associated with both vaccine hesitancy constructs. A total of 1,832 respondents were included in the final analysis of which 36.2% (range 5.6-52.2%) and 77.6% (range 38.3-91.2%) of them were classified as vaccine hesitant in terms of beliefs in vaccination benefits and concerns about new vaccines, respectively. Respondents from Pakistan had the highest vaccine hesitancy while those from Chile had the lowest. Being females, Muslim, having a non-healthcare-related job and not receiving a flu vaccination during the past 12 months were associated with poor beliefs of vaccination benefits. Those who were living in rural areas, Muslim, and those who did not received a flu vaccination during the past 12 months had relatively higher beliefs that new vaccines are riskier. High prevalence of vaccine hesitancy in some countries during the COVID-19 pandemic might hamper COVID-19 vaccination programs worldwide. Programs should be developed to promote vaccination in those sociodemographic groups with relatively high vaccine hesitancy.

Authors+Show Affiliations

Medical Research Unit, School of Medicine, Universitas Syiah Kuala, Banda Aceh, Indonesia. Tabriz Health Services Management Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. Department of Microbiology, School of Medicine, Universitas Syiah Kuala, Banda Aceh, Indonesia.Department of Statistics, Faculty of Mathematics and Natural Sciences, Universitas Syiah Kuala, Banda Aceh, Indonesia.Department of Family Medicine, School of Medicine, Universitas Syiah Kuala, Banda Aceh, Indonesia.Division of Surgery, ICAR-Indian Veterinary Research Institute, Bareilly, India.Department of Abdominal Surgery, Vladimir City Emergency Hospital, Vladimir, Russia.Medical Research Unit, School of Medicine, Universitas Syiah Kuala, Banda Aceh, Indonesia.Medical Research Unit, School of Medicine, Universitas Syiah Kuala, Banda Aceh, Indonesia. Master Program of Biology, Faculty of Mathematics and Natural Sciences, Universitas Syiah Kuala, Banda Aceh, Indonesia.Faculty of Medicine and General Surgery, Sudan University of Science and Technology, Sudan.Faculty of Medicine, University of Bahri, Sudan.Omdurman Teaching Hospital, Sudan.Faculty of Medicine, University of Khartoum, Omdurman, Sudan.Faculty of Medicine, Alzaiem Alazhari University, Sudan.Department of Internal Medicine, Faculty of Medicine, Sudan International University, Sudan.Department of Emergency Medicine, Faculty of Medicine of Tunis, University Tunis El Manar, Tunisia.Department of Emergency Medicine, Faculty of Medicine of Tunis, University Tunis El Manar, Tunisia.Department of Internal Medicine, Faculty of Medicine of Tunis, University of Tunis El Manar, Tunis, Tunisia.Department of Emergency Medicine, Faculty of Medicine of Tunis, University Tunis El Manar, Tunisia.Faculty of Dental medicine, University of Monastir, Tunisia.Faculty of Dental medicine, University of Monastir, Tunisia.Faculty of Medicine, Zagazig University, Egypt.Faculty of Medicine, Ain Shams University, Nasr City, Cairo, Egypt.Faculty of Medicine, Alexandria University, Egypt.Faculty of Medicine, Assiut University, Assiut, Egypt.Faculty of Medicine, Ain Shams University, Nasr City, Cairo, Egypt.Department of Public Health Dentistry, Indira Gandhi Institute of Dental Sciences, India.Department of General Medicine, Smt. Kashibai Navale Medical College and General Hospital, Pune, India.Division of Veterinary Parasitology, ICAR-Indian Veterinary Research Institute, Bareilly, India.Division of Veterinary Parasitology, ICAR-Indian Veterinary Research Institute, Bareilly, India. Department of Orthopedic Surgery, Yanan Hospital Affiliated to Kunming Medical University, Kunming, Yunnan, China.Department of Public Health and Postgraduate Program in Applied Health Sciences, Faculty of Medicine, Western Paraná State University, Brazil.Faculty of Medicine, University of La Frontera, Temuco, Chile.Faculty of Medicine, University of La Frontera, Temuco, Chile.Faculty of Medicine, University of La Frontera, Temuco, Chile.Faculty of Medicine, University of La Frontera, Temuco, Chile.Faculty of Medicine, University of La Frontera, Temuco, Chile.Department of Biochemistry, Faculty of Life Sciences, Ahmadu Bello University, Zaria, Nigeria.Babcock University, Ibadan, Nigeria.Afe Babalola University, Ado Ekiti, Nigeria.Covenant University Medical Center, Ota, Nigeria.Department of Medical Laboratory Sciences, Faculty of Health Sciences & Technology University of Nigeria, Nigeria.Babcock University, Ibadan, Nigeria.Research Fellow, Mayo Clinic, Rochester, NY, USA.Iranian Center of Excellence in Health Management, School of Management and Medical Informatics, Tabriz University of Medical Sciences, Tabriz, Iran.Department of Psychology, University of Sargodha, Sargodha, Pakistan.Department of Internal Medicine, Kabir Medical College, Gandhara University, Peshawar, Pakistan.Department of Public Health and Infectious Disease, Sapienza-University of Rome, Rome, Italy.Department of Pharmacy, Bgc Trust University Bangladesh, Bangladesh.Department of Life Sciences, Faculty of Medicine, Western Paraná State University, Brazil.Social Determinants of Health Research Center, Birjand University of Medical Sciences, Birjand, Iran.Department of Epidemiology, University of Michigan, Ann Arbor, MI, USA.Medical Research Unit, School of Medicine, Universitas Syiah Kuala, Banda Aceh, Indonesia. Tabriz Health Services Management Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. Department of Microbiology, School of Medicine, Universitas Syiah Kuala, Banda Aceh, Indonesia.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

34928187

Citation

Harapan, Harapan, et al. "Vaccine Hesitancy Among Communities in Ten Countries in Asia, Africa, and South America During the COVID-19 Pandemic." Pathogens and Global Health, vol. 116, no. 4, 2022, pp. 236-243.
Harapan H, Anwar S, Yufika A, et al. Vaccine hesitancy among communities in ten countries in Asia, Africa, and South America during the COVID-19 pandemic. Pathog Glob Health. 2022;116(4):236-243.
Harapan, H., Anwar, S., Yufika, A., Sharun, K., Gachabayov, M., Fahriani, M., Husnah, M., Raad, R., Abdalla, R. Y., Adam, R. Y., Khiri, N. M., Ismaeil, M. I., Ismail, A. Y., Kacem, W., Dahman, N. B., Teyeb, Z., Aloui, K., Hafsi, M., Ferjani, M., ... Mudatsir, M. (2022). Vaccine hesitancy among communities in ten countries in Asia, Africa, and South America during the COVID-19 pandemic. Pathogens and Global Health, 116(4), 236-243. https://doi.org/10.1080/20477724.2021.2011580
Harapan H, et al. Vaccine Hesitancy Among Communities in Ten Countries in Asia, Africa, and South America During the COVID-19 Pandemic. Pathog Glob Health. 2022;116(4):236-243. PubMed PMID: 34928187.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Vaccine hesitancy among communities in ten countries in Asia, Africa, and South America during the COVID-19 pandemic. AU - Harapan,Harapan, AU - Anwar,Samsul, AU - Yufika,Amanda, AU - Sharun,Khan, AU - Gachabayov,Mahir, AU - Fahriani,Marhami, AU - Husnah,Milda, AU - Raad,Rawan, AU - Abdalla,Rashed Ya, AU - Adam,Rashed Y, AU - Khiri,Namareg Me, AU - Ismaeil,Mohajer Ih, AU - Ismail,Asma Y, AU - Kacem,Wajdi, AU - Dahman,Nesrine Bh, AU - Teyeb,Zeineb, AU - Aloui,Khaoula, AU - Hafsi,Montacer, AU - Ferjani,Manel, AU - Deeb,Dalia A, AU - Emad,Dina, AU - Abbas,Kirellos Said, AU - Monib,Fatma A, AU - Sami,Farah S, AU - Subramaniam,R, AU - Panchawagh,Suhrud, AU - Anandu,Sunil, AU - Haque,Md Ariful, AU - Ferreto,Lirane Ed, AU - Briones,María Fc, AU - Morales,Rocío Bi, AU - Díaz,Sebastián Al, AU - Aburto,José To, AU - Rojas,Jorge Et, AU - Balogun,Emmanuel O, AU - Enitan,Seyi S, AU - Yomi,Akele R, AU - Durosinmi,Abiodun, AU - Ezigbo,Eyiuche D, AU - Adejumo,Esther N, AU - Babadi,Elham, AU - Kakemam,Edris, AU - Malik,Najma I, AU - Ullah,Irfan, AU - Rosiello,Dott F, AU - Emran,Talha B, AU - Wendt,Guilherme W, AU - Arab-Zozani,Morteza, AU - Wagner,Abram L, AU - Mudatsir,Mudatsir, Y1 - 2021/12/20/ PY - 2022/12/20/pmc-release PY - 2021/12/21/pubmed PY - 2022/5/26/medline PY - 2021/12/20/entrez KW - COVID-19 KW - Who Sage KW - vaccine acceptance KW - vaccine hesitancy KW - vaccine hesitant SP - 236 EP - 243 JF - Pathogens and global health JO - Pathog Glob Health VL - 116 IS - 4 N2 - Vaccine hesitancy is considered one of the greatest threats to the ongoing coronavirus disease 2019 (COVID-19) vaccination programs. Lack of trust in vaccine benefits, along with concerns about side effects of the newly developed COVID-19 vaccine, might significantly contribute to COVID-19 vaccine hesitancy. The objective of this study was to determine the level of vaccine hesitancy among communities in particular their belief in vaccination benefits and perceived risks of new vaccines. An online cross-sectional study was conducted in 10 countries in Asia, Africa, and South America from February to May 2021. Seven items from the WHO SAGE Vaccine Hesitancy Scale were used to measure a construct of belief in vaccination benefit, and one item measured perceived riskiness of new vaccines. A logistic regression was used to determine which sociodemographic factors were associated with both vaccine hesitancy constructs. A total of 1,832 respondents were included in the final analysis of which 36.2% (range 5.6-52.2%) and 77.6% (range 38.3-91.2%) of them were classified as vaccine hesitant in terms of beliefs in vaccination benefits and concerns about new vaccines, respectively. Respondents from Pakistan had the highest vaccine hesitancy while those from Chile had the lowest. Being females, Muslim, having a non-healthcare-related job and not receiving a flu vaccination during the past 12 months were associated with poor beliefs of vaccination benefits. Those who were living in rural areas, Muslim, and those who did not received a flu vaccination during the past 12 months had relatively higher beliefs that new vaccines are riskier. High prevalence of vaccine hesitancy in some countries during the COVID-19 pandemic might hamper COVID-19 vaccination programs worldwide. Programs should be developed to promote vaccination in those sociodemographic groups with relatively high vaccine hesitancy. SN - 2047-7732 UR - https://www.unboundmedicine.com/medline/citation/34928187/Vaccine_hesitancy_among_communities_in_ten_countries_in_Asia_Africa_and_South_America_during_the_COVID_19_pandemic_ DB - PRIME DP - Unbound Medicine ER -